

NCT02842424 Raw comparison:

Summary:
CHIA has 10 criteria while your personal folder has 12 criteria
Total found criteria: 10/10
Total not Found: 0/10
Total Extra: 2
This trial is VALID



╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╕
│ CHIA Criteria                                      │ Matching Personal Criteria                         │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╡
│ A positive history of chronic claudication         │ A positive history of chronic claudication         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Exercise-limiting claudication established by      │ Exercise-limiting claudication established by      │
│ history and direct observation during a screening  │ history and direct observation during a screening  │
│ walking test administered by the evaluating        │ walking test administered by the evaluating        │
│ vascular surgeon                                   │ vascular surgeon                                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Arterial occlusive disease per ankle Brachial      │ Arterial occlusive disease per ankle Brachial      │
│ index measurements and/or other imaging modalities │ index measurements and/or other imaging modalities │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Stable blood pressure regimen stable lipid regimen │ Stable blood pressure regimen stable lipid regimen │
│ stable diabetes regimen and risk factor control    │ stable diabetes regimen and risk factor control    │
│ for 6 weeks                                        │ for 6 weeks                                        │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Rest pain or tissue loss due to PAD (Fontaine      │ Rest pain or tissue loss due to PAD (Fontaine      │
│ stage III and IV)                                  │ stage III and IV)                                  │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ acute lower extremity ischemic event secondary to  │ acute lower extremity ischemic event secondary to  │
│ thromboembolic disease or acute trauma             │ thromboembolic disease or acute trauma             │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Walking capacity significantly limited by          │ Walking capacity significantly limited by          │
│ conditions other than claudication including leg   │ conditions other than claudication including leg   │
│ (joint/musculoskeletal neurologic) and systemic    │ (joint/musculoskeletal neurologic) and systemic    │
│ (heart lung disease) pathology                     │ (heart lung disease) pathology                     │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Current use of either ACE inhibitors or            │ Current use of either ACE inhibitors or            │
│ angiotensin II receptor blockers                   │ angiotensin II receptor blockers                   │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ Chronic kidney disease with estimated Glomerular   │ Chronic kidney disease with estimated Glomerular   │
│ Filtration Rate < 30 ml/min/1 73 m2                │ Filtration Rate \< 30 ml/min/1 73 m2               │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┤
│ History of bilateral severe renal artery stenosis  │ History of bilateral severe renal artery stenosis  │
│ and 7) History of angioedema related to previous   │ and 7) History of angioedema related to previous   │
│ ACE-inhibitor treatment or known hypersensitivity  │ ACE-inhibitor treatment or known hypersensitivity  │
│ to ramipril or other ACE inhibitors                │ to ramipril or other ACE inhibitors                │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╛



Everything was Found



╒═══════════════════════════════════╕
│ Extra Personal Criteria           │
╞═══════════════════════════════════╡
│ Must have maximum age of 90 Years │
├───────────────────────────────────┤
│ Must have minimum age of 18 Years │
╘═══════════════════════════════════╛